Stem Cell Therapy For Stroke Clinical Trials

Stroke is the leading cause of permanent disability in the u s striking nearly 800 000 people each year according to the centers for disease control and prevention.

Stem cell therapy for stroke clinical trials.

Today the uc irvine branch of the ucla uci alpha stem cell clinic announces its participation in a new clinical research study that aims to improve function in people with chronic disability as a result of an ischemic stroke a stroke that occurs when blood flow to the brain is blocked such as by a clot. The stem cell clinical trial targets acute ich treated within 72 hours of stroke onset. Researching stem cell therapy for hemorrhagic stroke. In the last decade there has been preclinical research that led to a small number of early phase clinical trials using mesenchymal stem cells mscs as a possible treatment to reverse damage from hemorrhagic stroke.

Stem cell clinical trials for stroke are trying to uncover how this kind of treatment can improve the lives of stroke patients. Our preclinical experiments showed that the effects of treatment aren t as prominent after delay dr.